We successfully replicated our findings from the ROSMAP cohort, showing that there was no significant difference in CD8 + T cell abundance between AD and controls, both by the Wilcoxon test (p = 0.20) and by AD status in a multivariate linear regression (p = 0.32; Figure 3F; Table 2). This evidence concerns the gene CD8A and Alzheimer disease.